Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.720
0.00 (0.00%)
Nov 4, 2024, 4:00 PM EST - Market closed
Ikena Oncology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -66.71 | -68.17 | -68.77 | -34.12 | -44.26 | -16.82 | Upgrade
|
| Depreciation & Amortization | 0.86 | 1.02 | 0.75 | 0.54 | 0.3 | 0.24 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.84 | 0.01 | 0.17 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.74 | 1.74 | - | - | 11.14 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.71 | -2.02 | 0.06 | - | - | - | Upgrade
|
| Stock-Based Compensation | 7.03 | 7.63 | 7.53 | 5.18 | 1.8 | 1.17 | Upgrade
|
| Other Operating Activities | 1.94 | 1.71 | 1.28 | 1.17 | 0.96 | -0.12 | Upgrade
|
| Change in Accounts Payable | -3.21 | -2.87 | -0.29 | 0.36 | 0.52 | -1.33 | Upgrade
|
| Change in Unearned Revenue | -1.84 | -9.16 | -15.62 | -30.99 | -9.19 | 64.96 | Upgrade
|
| Change in Other Net Operating Assets | -11.57 | -9.64 | 0.77 | -2.41 | 0.9 | -0.17 | Upgrade
|
| Operating Cash Flow | -72.62 | -79.74 | -74.11 | -60.25 | -37.83 | 47.93 | Upgrade
|
| Capital Expenditures | -0.26 | -0.41 | -1.43 | -1.76 | -0.77 | -0.32 | Upgrade
|
| Cash Acquisitions | - | - | - | - | 3.69 | - | Upgrade
|
| Investment in Securities | 7.47 | 64.56 | -97.85 | - | - | - | Upgrade
|
| Investing Cash Flow | 7.45 | 64.14 | -99.28 | -1.76 | 2.92 | -0.32 | Upgrade
|
| Issuance of Common Stock | - | 37.56 | 1.1 | 131.88 | 0.07 | 0.03 | Upgrade
|
| Repurchase of Common Stock | -0.11 | -0.66 | - | - | - | - | Upgrade
|
| Other Financing Activities | 39.09 | 39.09 | - | - | -0.06 | - | Upgrade
|
| Financing Cash Flow | 38.98 | 75.98 | 1.1 | 131.74 | 116.18 | 16.32 | Upgrade
|
| Net Cash Flow | -26.19 | 60.38 | -172.3 | 69.73 | 81.28 | 63.93 | Upgrade
|
| Free Cash Flow | -72.88 | -80.16 | -75.54 | -62.01 | -38.59 | 47.61 | Upgrade
|
| Free Cash Flow Margin | -3952.49% | -875.08% | -483.67% | -200.14% | -419.75% | 346.19% | Upgrade
|
| Free Cash Flow Per Share | -1.55 | -1.92 | -2.09 | -2.22 | -13.95 | 17.98 | Upgrade
|
| Levered Free Cash Flow | -43.63 | -47.98 | -41.98 | -21 | -23 | 8.71 | Upgrade
|
| Unlevered Free Cash Flow | -43.63 | -47.98 | -41.98 | -21 | -23 | 8.71 | Upgrade
|
| Change in Net Working Capital | 6.14 | 9.08 | 4.51 | 3.63 | -3.49 | -19.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.